News

The Gregg Museum's "Art's Work in the Age of Biotechnology: Shaping Our Genetic Futures" is less concerned with answering big questions than in finding head-spinning new ways to ask them.
Miniature models of human organs may provide a more accurate predictor of drug efficacy than animal testing.
This Scientist Explains Complex Biotech With Food, Art And Empathy By Katheryn Thayer, Former Staff. Design, art, tech, and creative people pushing those fields forward.
Gold Derby has an exclusive first look at the book. The Art and Making of Mickey 17 is written by Simon Ward, who previously wrote Art and Making ofbooks for Bong’s filmsSnowpiercerandOkja.
Qihan Biotech today disclosed the initiation of a program to create immunologically privileged human stem cells.
Concept Life Sciences’ recent acquisition of Aquila BioMedical has quickly produced a return—an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs.
Evaxion Biotech (EVAX) obtains preclinical Proof-of-Concept, PoC, for its precision cancer vaccine concept targeting non-conventional ERV tumor antigens shared across patients.
A biotech startup company aims to supply organs from genetically-engineered pigs for human transplants, which they plan to begin later in 2021 or 2022.
Editas Medicine pivots to in vivo gene editing, extends cash runway to Q2 2027, and reduces its workforce by 65%. The company reports breakthroughs in HSC and liver editing.